Safety Alerts & Recalls
What does this mean?
This recall for Loxapine Capsules 5mg, 10 mg, 25 mg, 50 mg and Loxitane Capsules 10 mg from Watson Laboratories was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Loxapine Capsules or Loxitane Capsules and would like a copy of the current patient information leaflet or if you have questions about your medicines, you can ask your pharmacist or doctor.
Watson Laboratories Recalls Several Lots of Loxapine Capsules
Watson Laboratories is recalling several lots of Loxapine Capsules, 5 mg, 10 mg, 25 mg, 50 mg, and the brand name of loxapine called Loxitane Capsules, 10 mg.. The following lot numbers are being recalled because these lots included an outdated patient information leaflet for the drug: Loxapine Capsules, 5 mg: Lot 108094A
Loxapine Capsules, 10 mg: Lot numbers 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, and 456251A
Loxapine Capsules, 25 mg: Lot numbers 101696A, 110829A, 123685A, 123687A
Loxapine Capsules, 50 mg: Lot numbers 104432A, 104433A, 121344A, 127024A, 144290A
Loxitane (Loxapine Succinate) Capsules, 10 mg: Lot number 22478A
Loxapine is used in the treatment of certain mental health issues. Loxapine is also sold under other brand names. Only the lots, strengths and brands of loxapine listed above were involved in this recall.
To view the FDA notice about this recall, please visit: more information here